Miura, Satoru
Koh, Yasuhiro
Azuma, Koichi
Yoshioka, Hiroshige
Koyama, Kenichi
Teraoka, Shunsuke
Ishii, Hidenobu
Kibata, Kayoko
Ozawa, Yuichi
Tokito, Takaaki
Oyanagi, Jun
Shimokawa, Toshio
Kurata, Takayasu
Yamamoto, Nobuyuki
Tanaka, Hiroshi
Article History
Received: 28 July 2022
Accepted: 21 December 2022
First Online: 3 January 2023
Declarations
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki. All patients provided written informed consent before enrollment in the study. The study protocol was approved by the Certified Review Board of Wakayama Medical University.
: Not applicable.
: The authors declare the following financial interests/personal relationships, which may be considered potential competing interests. Satoru Miura reports personal fees from Nippon Boehringer-Ingelheim and AstraZeneca. Yasuhiro Koh reports grants from Boehringer-Ingelheim and AstraZeneca. Koichi Azuma reports personal fees and grants from AstraZeneca. Hiroshige Yoshioka reports personal fees and grants from Nippon Boehringer-Ingelheim. Takayasu Kurata reports personal fees from Nippon Boehringer-Ingelheim and AstraZeneca. Nobuyuki Yamamoto reports personal fees from AstraZeneca and grants from Nippon Boehringer-Ingelheim. Hiroshi Tanaka reports personal fees and grants from AstraZeneca. The remaining authors declare no relevant conflicts of interest related to this study.